Vice President, CETA New Product Planning (NPP) & Forecasting

Are you a strategic thinker with a commercial mindset and a proven track record in the pharmaceutical industry? Do you have a passion for driving and executing high-impact strategies? If so, Novo Nordisk has an exciting opportunity for you!

We are seeking a dynamic leader for the role of Vice President, Cardiovascular & Emerging Therapy Areas (CETA) New Product Planning and Forecasting. In this pivotal position, you will shape the future growth of Novo Nordisk’s emerging therapies, driving innovation and commercial success, and making a difference in the lives of patients worldwide.

Preferably based in the vibrant city of Copenhagen, Denmark, this role is perfect for a visionary leader ready to take on new challenges and drive the success of Novo Nordisk’s cutting-edge therapies.

The position
As the Vice President, CETA NPP & Forecasting, you will report to the Corporate Vice President, CETA Early Portfolio and Insights, managing the strategy of the broadest pipeline and portfolio overseeing three key therapy areas: MASH, Cardiovascular Disease, Chronic Kidney Disease. The role offers a significant impact on the company's strategic direction and commercial outcomes.
In this role, you will be at the forefront of all commercial deliverables for early-stage pipeline projects in accordance with the Global Project Framework. You will collaborate closely with the commercial assets lead in CETA for asset evaluations.

Your responsibilities will include:

• Taking overall responsibility for all New Product Planning input to internal and external innovation and business development projects, including providing commercial input for all projects going to the Scientific Committee, Executive Development Committee, and Spring review.
• Owning all forecasting deliverables, including long-term forecasts, and working with the portfolio strategy, access & pricing forecasting team, commercial and the business development evaluation team.
• Effectively managing the allocated budget and related financial deliverables, ensuring all project risks are identified, flagged, and mitigated throughout the project development plan.
• Partnering with the competitive intelligence and market insight team to ensure all input to relevant projects or forecasting tasks are met.
• Managing a talented team of specialists and experts. Delivering strong leadership to develop the area with a focus on a purpose-driven culture, robust performance mindset, and an open and honest culture. This includes driving diversity, succession planning, and the development of future talents and leaders.
• Part of the Corporate Vice President Leadership team contributing to transformation and impact.

Qualifications

• Master’s degree preferred in business or science related field.
• +10 years of pharmaceutical industry experience, preferably across the value chain i.e., early product development, forecasting, lifecycle management, commercial strategy (both short and long-term), affiliate execution including P&L understanding.
• Experience working operationally with affiliates or with business development, portfolio, pipeline and phase 3 assets.
• Experience working with R&D, marketing, pharmaceutical products, or medical devices in a large organization.
• Experience entering new therapy areas and managing alliances and partnerships.
• Strong leadership experience – delivering proven results through a high performing team.
• The ability to navigate complexity by managing multiple projects, delivering high-quality results on time, and a strong results-oriented approach.
• Excellent stakeholder management skills, good communication and presentation skills.
• A strategic and analytical mindset.
• Readiness to embrace change and bring a high energy level, curiosity and ambition.
• Fluency in written and spoken English.

About the Department

The Early Portfolio and Insights Area is located in Søborg, Denmark and manages the broadest and most complex pipeline in the therapy areas of MASH, Chronic Kidney Disease, and Cardiovascular Disease. The department is rapidly growing and is crucial for Novo Nordisk’s long-term sales and growth. This will entail not just managing projects but also shaping the future of healthcare.

Our headquarters, where this role is based, is a hub of innovation and collaboration, housing over 1000 employees. Here, you will find a dynamic and supportive environment that fosters creativity and excellence.

Working at Novo Nordisk

At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales – we’re all working to move the needle on patient care.

Contact
For further information, please contact Senior Executive Search Partner, Anette Schmidt Jepsen at [email protected] or get to know us better by visiting www.novonordisk.com/careers. If you believe that you are qualified and willing to take the challenge, please send your CV and relevant documentation directly via our online application tool.

Deadline
Please submit your application via our online application tool by Friday 31 January 2025.
You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. 

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.